Table 6.
Six canola (Brassica napus L.) products are listed in the United States Food and Drug Administration’s (FDA) Generally Recognized as Safe (GRAS) notice inventory since the inventory was established in 1998. In all applications, the FDA had no questions regarding the GRAS status of the product. Current as of September 2021.
| GRAS Number | Notifier | Substance | Intended Use | Date of Closure | FDA Response |
|---|---|---|---|---|---|
| 683 | DSM Innovation Company | Canola protein isolate | Dietary protein Food processing |
2017 | no questions |
| 682 | Cargill Inc. | Lecithin from canola | Food processing Dietary fat Dietary choline |
2017 | no questions |
| 533 | American Lecithin Company | Lecithin from canola | Food processing Dietary fat Dietary choline |
2015 | no questions |
| 425 | Danone Trading B.V. | Canola oil (low-erucic-acid rapeseed oil) | Dietary fat (infant formula) | 2012 | no questions |
| 386 | BioExx Specialty Proteins, Ltd. | Canola protein isolate and hydrolyzed canola protein isolate | Food processing Dietary protein |
2011 | no questions |
| 327 | Archer Daniels Midland Company | Cruciferin-rich canola/rapeseed protein isolate and napin-rich canola/rapeseed protein isolate | Dietary protein | 2010 | no questions |